March 24, 2025
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
New from ACHP:
- ACHP Letter on Recommendations for Anticompetitive Regulations Task Force
- ACHP Statement on the Release of the MAHA Commission Report on Childhood Chronic Disease
- ACHP Statement on Increasing Risk Adjustment Audits in Medicare Advantage
- ACHP Statement on House Bill Threatening Medicaid Access and Marketplace Stability
- ACHP Letter to Office of Management and Budget Director Vought on Deregulation in Health Care
- Chronic Disease Pledge Bright Spot: Baylor Scott & White Health Plan’s Diabetes Management Program
